The Centers for Disease Control and Prevention (CDC) recently announced a pediatric immunization-focused Notice of Funding Opportunity (NOFO) – US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children (grants/view-opportunity.html?oppId=328354″>RFA-IP-21-002).
The NOFO aims to support grantees with developing and implementing standard research protocols to conduct prospective active surveillance for the following viral illnesses, including COVID-19, and the effectiveness of associated vaccines among pediatric patients at medical institutions:
- Acute gastroenteritis (AGE) due to norovirus, rotavirus and other enteric viruses;
- Acute respiratory illnesses (ARI) due to respiratory viruses including, but not limited to, influenza, RSV, parainfluenza viruses, human metapneumovirus, rhinoviruses, enteroviruses (including EV-D68), adenoviruses, and coronaviruses (including SARS-CoV-2); and
- Acute flaccid myelitis (AFM) syndrome and multisystem inflammatory syndrome in children (MIS-C).
Collected information will be used to guide best practices for diagnosis and treatment protocols and vaccine recommendations and to evaluate the public health impact of vaccination and public health programs.
The NOFO is open to a broad range of applicants, including nonprofits and public and private non-profit institutions of higher education. The CDC expects to provide seven awards ranging from $1.6 million to $1.96 million, with total program funding estimated at $68.25 million. Funding will be awarded over a five-year project period (September 1, 2021 to August 31, 2026).
The letter of intent is due January 7, 2021. Applications are due February 8, 2021.